This monthly feature will help readers keep current on new drugs, new indications, dosage forms, and safety-related changes in labeling or use. Efforts have been made to ensure the accuracy of this information; however, if there are any questions, please let me know at bakerdan@wsu.edu.
Immune reconstitution syndrome has been reported in patients treated with combination antiretroviral therapy. Autoimmune disorders (such as Graves' disease, polymyositis, and Guillain-Barré syndrome) have also been reported. http://www.fda.gov/Safety/MedWatch/SafetyInformation/ ucm318611.htm
Etravirine
Intelence (Tibotec Therapeutics) Immune reconstitution syndrome has been reported in patients treated with combination antiretroviral therapy. Autoimmune disorders (such as Graves' disease, polymyositis, and Guillain-Barré syndrome) have also been reported. http://www.fda.gov/Safety/MedWatch/SafetyInformation/ ucm186431.htm (continued)
